Shah, N.J.; Della Pia, A.; Wu, T.; Williams, A.; Weber, M.; Sinclaire, B.; Gourna Paleoudis, E.; Alaoui, A.; Lev-Ari, S.; Adams, S.;
et al. Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers 2024, 16, 2223.
https://doi.org/10.3390/cancers16122223
AMA Style
Shah NJ, Della Pia A, Wu T, Williams A, Weber M, Sinclaire B, Gourna Paleoudis E, Alaoui A, Lev-Ari S, Adams S,
et al. Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers. 2024; 16(12):2223.
https://doi.org/10.3390/cancers16122223
Chicago/Turabian Style
Shah, Neil J., Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber, Brittany Sinclaire, Elli Gourna Paleoudis, Adil Alaoui, Shaked Lev-Ari, Shari Adams,
and et al. 2024. "Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials" Cancers 16, no. 12: 2223.
https://doi.org/10.3390/cancers16122223
APA Style
Shah, N. J., Della Pia, A., Wu, T., Williams, A., Weber, M., Sinclaire, B., Gourna Paleoudis, E., Alaoui, A., Lev-Ari, S., Adams, S., Kaufman, J., Parikh, S. B., Tonti, E., Muller, E., Serzan, M., Cheruku, D., Lee, A., Sridhar, A., Hee, B. P.,
... Atkins, M. B.
(2024). Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers, 16(12), 2223.
https://doi.org/10.3390/cancers16122223
